Tensions rise as Bonitas and Medscheme clash ahead of court showdown
Bonitas, Medscheme, and PHA trade accusations as court papers, whistleblower claims, and a CMS probe intensify the battle over medical scheme contracts.
#Afrocentric
Bonitas-Medscheme split: what the CMS probe means for members
The scheme and the regulator say a narrowly focused investigation will not halt the transition – but members should brace for some operational changes.
Bonitas’ dispute with Medscheme heads to court
Bonitas’ decision to change administrators comes amid a CMS investigation and High Court proceedings involving its former service provider.
Bonitas commits to co-operating with CMS investigation
After concluding its section 43 inquiry into Bonitas, the CMS has determined that the allegations merit a further forensic investigation.
Sanlam’s split with Bonitas paves the way for exclusive Fedhealth partnership
After months of speculation, Sanlam has officially partnered with Fedhealth as its exclusive open medical scheme provider.
Strong life insurance sales drive Sanlam’s 14% interim profit growth
Sanlam gained market share in individual underwritten life insurance, supported by strong single-premium growth and stable persistency in the affluent segment.
Sanlam’s India operations pave the way to stellar performance in 2023
All eyes are on the group’s pan-African joint venture with Allianz, to see whether it will mirror the achievements of Sanlam’s interests in India.
Thursday briefing: a round-up of recent financial services news
SA unit trust returns | Flood claims | Santam profits warning | Insuretech raises $17m | Sanlam-AfroCentric deal | Business account fees.
Sanlam seeks controlling stake in AfroCentric
Sanlam announced this week that it has submitted a letter to the board of AfroCentric Investment Corporation Limited (AfroCentric), expressing Sanlam’s intention to acquire AfroCentric shares that would result in Sanlam acquiring a […]
